The Clorox Company
86.40USD
-2.2600 (-2.55%)
Fetching financial statements from SEC filings…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on CLX.
| In $M except per-share | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,670 | 1,673 | 1,429 | 1,988 | 1,668 | 1,686 | 1,762 | 1,903 |
| Cost of Revenue | 948 | 951 | 833 | 1,064 | 924 | 948 | 955 | 1,019 |
| Gross Profit | 722 | 722 | 596 | 924 | 744 | 738 | 807 | 884 |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | 187 | 157 | 80 | 332 | 186 | 193 | 99 | 216 |
| EPS (Diluted) | $1.54 | $1.29 | $0.65 | $2.68 | $1.50 | $1.54 | $0.80 | $1.73 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)